Growth Metrics

Gyre Therapeutics (GYRE) Current Taxes (2022 - 2026)

Gyre Therapeutics has reported Current Taxes over the past 4 years, most recently at $2.9 million for Q4 2025.

  • Quarterly Current Taxes rose 3.85% to $2.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 million through Dec 2025, up 3.85% year-over-year, with the annual reading at $2.9 million for FY2025, 3.85% up from the prior year.
  • Current Taxes was $2.9 million for Q4 2025 at Gyre Therapeutics, up from $2.6 million in the prior quarter.
  • Over five years, Current Taxes peaked at $6.5 million in Q1 2024 and troughed at $569000.0 in Q1 2025.
  • The 4-year median for Current Taxes is $2.7 million (2024), against an average of $2.9 million.
  • Year-over-year, Current Taxes surged 140.55% in 2023 and then plummeted 91.21% in 2025.
  • A 4-year view of Current Taxes shows it stood at $2.1 million in 2022, then surged by 140.55% to $5.1 million in 2023, then crashed by 43.98% to $2.8 million in 2024, then rose by 3.85% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Current Taxes are $2.9 million (Q4 2025), $2.6 million (Q3 2025), and $1.1 million (Q2 2025).